比较欧洲国家在 COVID-19 大流行期间的疫苗接种率和加强针接种率及其对超额死亡率的影响。

Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries.

机构信息

Sendai Viralytics LLC, Acton, MA, United States.

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, United States.

出版信息

Front Immunol. 2023 Jul 6;14:1151311. doi: 10.3389/fimmu.2023.1151311. eCollection 2023.

Abstract

AIM

To evaluate the effect of vaccination/booster administration dynamics on the reduction of excess mortality during COVID-19 infection waves in European countries.

METHODS

We selected twenty-nine countries from the OurWorldInData project database according to their population size of more than one million and the availability of information on dominant SARS-CoV-2 variants during COVID-19 infection waves. After selection, we categorized countries according to their "faster" or "slower" vaccination rates. The first category included countries that reached 60% of vaccinated residents by October 2021 and 70% by January 2022. The second or "slower" category included all other countries. In the first or "faster" category, two groups, "boosters faster'' and "boosters slower" were created. Pearson correlation analysis, linear regression, and chi-square test for categorical data were used to identify the association between vaccination rate and excess mortality. We chose time intervals corresponding to the dominance of viral variants: Wuhan, Alpha, Delta, and Omicron BA.1/2.

RESULTS AND DISCUSSION

The "faster" countries, as opposed to the "slower" ones, did better in protecting their residents from mortality during all periods of the SARS-CoV-2 pandemic and even before vaccination. Perhaps higher GDP per capita contributed to their better performance throughout the pandemic. During mass vaccination, when the Delta variant prevailed, the contrast in mortality rates between the "faster" and "slower" categories was strongest. The average excess mortality in the "slower" countries was nearly 5 times higher than in the "faster" countries, and the odds ratio (OR) was 4.9 (95% CI 4.4 to 5.4). Slower booster rates were associated with significantly higher mortality during periods dominated by Omicron BA.1 and BA.2, with an OR of 2.6 (CI 95%. 2.1 to 3.3). Among the European countries we analyzed, Denmark, Norway, and Ireland did best, with a pandemic mortality rate of 0.1% of the population or less. By comparison, Bulgaria, Serbia, and Russia had a much higher mortality rate of up to 1% of the population.

CONCLUSION

Thus, slow vaccination and booster administration was a major factor contributing to an order of magnitude higher excess mortality in "slower" European countries compared to more rapidly immunized countries.

摘要

目的

评估接种/加强针接种动态对降低欧洲国家 COVID-19 感染浪潮期间超额死亡率的影响。

方法

我们根据人口规模超过 100 万以及 COVID-19 感染浪潮期间主要 SARS-CoV-2 变体的信息可用性,从 OurWorldInData 项目数据库中选择了 29 个国家。选择后,我们根据其“更快”或“更慢”的疫苗接种率对国家进行分类。第一类包括到 2021 年 10 月达到 60%接种居民和到 2022 年 1 月达到 70%接种居民的国家。第二类或“更慢”的类别包括所有其他国家。在第一类或“更快”的类别中,创建了“加强针接种更快”和“加强针接种更慢”两个组。我们使用 Pearson 相关分析、线性回归和卡方检验对分类数据进行分析,以确定疫苗接种率与超额死亡率之间的关联。我们选择与病毒变体主导时期相对应的时间间隔:武汉、Alpha、Delta 和 Omicron BA.1/2。

结果与讨论

与“更慢”的国家相比,“更快”的国家在 COVID-19 大流行的所有时期以及疫苗接种之前更好地保护了其居民免受死亡的影响。也许更高的人均 GDP 有助于他们在整个大流行期间表现更好。在大规模接种疫苗期间,当 Delta 变体占主导地位时,“更快”和“更慢”类别之间的死亡率差异最为明显。在“更慢”的国家,平均超额死亡率几乎是“更快”国家的 5 倍,优势比(OR)为 4.9(95%CI 4.4 至 5.4)。在 Omicron BA.1 和 BA.2 占主导地位的时期,较慢的加强针接种率与死亡率显著升高相关,OR 为 2.6(95%CI 95% 为 2.1 至 3.3)。在我们分析的欧洲国家中,丹麦、挪威和爱尔兰表现最好,大流行死亡率为人口的 0.1%或更低。相比之下,保加利亚、塞尔维亚和俄罗斯的死亡率高达人口的 1%。

结论

因此,缓慢的疫苗接种和加强针接种是导致“更慢”的欧洲国家与更快接种疫苗的国家相比,超额死亡率高出一个数量级的主要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3607/10357837/057834e6fd94/fimmu-14-1151311-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索